We Strategically Partner With Other Innovator Healthcare Companies 

CLINICAL DEVELOPMENT

We strategically partner and collaborate with other innovator healthcare companies to in-/out-license or co-develop drug candidates in the clinical phase of the development process.

The DELTA HEALTH team has over two decades of drug development expertise in the following therapeutic areas:

• Cardiovascular Diseases

• Dermatology

• Endocrinology

• Gastroenterology

• Allergy

• Nephrology

• Hematology

• Neurology

• Oncology

• Ophthalmology

• Urology

• Pain Management

• Immunology / Autoimmune

• Pulmonary / Respiratory

• Psychiatry

• Rheumatology

• Infectious Diseases

• Central Nervous System

​

In addition to the United States Food and Drug Administration (FDA) and Health Canada, the DELTA team also has considerable experience in working with the European Medicines Agency (EMA), the Ministry of Health Mexico and Argentina Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT).

​

For further information please contact: 

​